Arisaig Partners (Asia)’s iHuman IH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,214,002
Closed -$2.17M 1
2024
Q2
$2.17M Sell
1,214,002
-721,568
-37% -$1.34M 100% 1
2024
Q1
$3.29M Sell
1,935,570
-642,429
-25% -$1.49M 100% 1
2023
Q4
$7.91M Hold
2,577,999
5.14% 5
2023
Q3
$7.79M Hold
2,577,999
4.69% 5
2023
Q2
$7.63M Hold
2,577,999
3.66% 5
2023
Q1
$8.35M Hold
2,577,999
2.88% 5
2022
Q4
$6.29M Hold
2,577,999
2.87% 6
2022
Q3
$5.67M Hold
2,577,999
2.6% 6
2022
Q2
$6.08M Hold
2,577,999
2.43% 5
2022
Q1
$5.34M Hold
2,577,999
1.25% 7
2021
Q4
$7.22M Buy
+2,577,999
New +$11.1M 1.22% 7

Other funds holding IH

Arisaig Partners (Asia)'s IH Position: Q3 2024 in Review

Arisaig Partners (Asia) sold out of iHuman (IH) in Q3 2024, closing a stake of 1,214,002 shares — an estimated $2.17M sold.

Arisaig Partners (Asia) first reported a position in IH in Q4 2021 and held it in 11 quarters. The position peaked at $8.35M in Q1 2023. 6 funds tracked by Wall St. Rank hold IH as of Q3 2024.

  • Arisaig Partners (Asia) reported no remaining iHuman position as of Q3 2024 after selling out during the quarter.
  • Arisaig Partners (Asia) sold 1,214,002 iHuman shares in Q3 2024, an estimated $2.17M.
  • Arisaig Partners (Asia) first reported a position in iHuman in Q4 2021 and held it in 11 quarters.
  • Arisaig Partners (Asia)'s iHuman position peaked at $8.35M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held iHuman as of Q3 2024.

Based on Arisaig Partners (Asia)'s 13F filing for Q3 2024.